feed,title,long_url,short_url
Benzinga,Kala Pharma Reveals Safety Data From Stem Cell Therapy Trial For Corneal Defect Impacting Around 240K People In Developed Nations,https://benzinga.com/general/biotech/23/03/31512512/kala-pharma-reveals-safety-data-from-stem-cell-therapy-trial-for-corneal-defect-impacting-around-,https://da.gd/Zhbz
